Suchergebnisse

The market expects Herc Holdings (HRI) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus

Herc Holdings (HRI) came out with quarterly earnings of $1.43 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $1.87 per share a year ago. These

The market expects Harmony Biosciences Holdings, Inc. (HRMY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Harmony Biosciences Holdings, Inc. (HRMY) or Acadia Pharmaceuticals (ACAD). But which of

Healthcare Realty Trust (HR) came out with quarterly funds from operations (FFO) of $0.41 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to FFO of $0.41 per share a

For Immediate Release

Chicago, IL – July 27, 2026 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss

For Immediate Release

Chicago, IL – July 29, 2026 – Stocks in this week’s article are Harmony Biosciences Holdings HRMY, Invesco IVZ, General Motors GM, Hewlett Packard Enterprise HPE and Quanex

Herc Holdings Inc. (HRI) reported second-quarter 2026 adjusted earnings of $1.43 per share, beating the Zacks Consensus Estimate of 76 cents by 88.2%. However, earnings declined on a year-over-year

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the